Genomic Health, Inc. (GHDX) Tops Q2 EPS by 8cm, Offers Q3 Rev. Guidance
Tweet Send to a FriendGet Alerts GHDX Hot Sheet
Price: $37.24 +0.08%
EPS Growth %: -250.0%
Financial Fact:
Other income (expense), net: -6K
Today's EPS Names:
CSS, STV, GIGM, More
EPS Growth %: -250.0%
Financial Fact:
Other income (expense), net: -6K
Today's EPS Names:
CSS, STV, GIGM, More
Trade GHDX Now!
Genomic Health, Inc. (NASDAQ: GHDX) reported Q2 EPS of $0.06, $0.08 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $57.6 million versus the consensus estimate of $58.24 million.
Genomic Health, Inc. sees FY2012 revenue of $230-$240 million, versus the consensus of $238.9 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Genomic Health, Inc. sees FY2012 revenue of $230-$240 million, versus the consensus of $238.9 million.
For earnings history and earnings-related data on Genomic Health, Inc. (GHDX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Analog Devices, Inc. (ADI) Reports In-Line Q2 EPS, Guidance Light
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
